The inhibition of CXCR4 restrained stem cells-like properties (metastasis and chemoresistance) of CD133+/CXCR4+ stem cells derived from human NSCLC tumor tissues [38]. The gene discussed is PROM1; the disease is non-small cell lung carcinoma.